137 related articles for article (PubMed ID: 37003181)
1. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1.
Chemla A; Arena G; Saraiva C; Berenguer-Escuder C; Grossmann D; Grünewald A; Klein C; Seibler P; Schwamborn JC; Krüger R
Stem Cell Res; 2023 Jun; 69():103085. PubMed ID: 37003181
[TBL] [Abstract][Full Text] [Related]
2. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1.
Chemla A; Arena G; Onal G; Walter J; Berenguer-Escuder C; Grossmann D; Grünewald A; Schwamborn JC; Krüger R
Stem Cell Res; 2023 Sep; 71():103145. PubMed ID: 37364399
[TBL] [Abstract][Full Text] [Related]
3. Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease Patients.
Berenguer-Escuder C; Grossmann D; Massart F; Antony P; Burbulla LF; Glaab E; Imhoff S; Trinh J; Seibler P; Grünewald A; Krüger R
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31888276
[TBL] [Abstract][Full Text] [Related]
4. Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease.
Berenguer-Escuder C; Grossmann D; Antony P; Arena G; Wasner K; Massart F; Jarazo J; Walter J; Schwamborn JC; Grünewald A; Krüger R
Hum Mol Genet; 2020 May; 29(8):1353-1364. PubMed ID: 32280985
[TBL] [Abstract][Full Text] [Related]
5. Mutations in
Grossmann D; Berenguer-Escuder C; Bellet ME; Scheibner D; Bohler J; Massart F; Rapaport D; Skupin A; Fouquier d'Hérouël A; Sharma M; Ghelfi J; Raković A; Lichtner P; Antony P; Glaab E; May P; Dimmer KS; Fitzgerald JC; Grünewald A; Krüger R
Antioxid Redox Signal; 2019 Dec; 31(16):1213-1234. PubMed ID: 31303019
[No Abstract] [Full Text] [Related]
6. Miro1 Marks Parkinson's Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson's Models.
Hsieh CH; Li L; Vanhauwaert R; Nguyen KT; Davis MD; Bu G; Wszolek ZK; Wang X
Cell Metab; 2019 Dec; 30(6):1131-1140.e7. PubMed ID: 31564441
[TBL] [Abstract][Full Text] [Related]
7. Steady-State Levels of Miro1 Linked to Phosphorylation at Serine 156 and Mitochondrial Respiration in Dopaminergic Neurons.
Schwarz L; Fitzgerald JC
Cells; 2022 Apr; 11(8):. PubMed ID: 35455950
[TBL] [Abstract][Full Text] [Related]
8. Generation of R272Q, S156A and K572R RHOT1/Miro1 point mutations in iPSCs from a healthy individual using FACS-assisted CRISPR/Cas9 genome editing.
Schwarz L; Casadei N; Fitzgerald JC
Stem Cell Res; 2021 Aug; 55():102469. PubMed ID: 34359002
[TBL] [Abstract][Full Text] [Related]
9. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson's associated GBA gene.
X-Q Chen C; Deneault E; Abdian N; You Z; Sirois J; Nicouleau M; Shlaifer I; Villegas L; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
Stem Cell Res; 2022 Oct; 64():102919. PubMed ID: 36130446
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
Beevers JE; Caffrey TM; Wade-Martins R
Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
12. Generation of isogenic control DJ-1-delP GC13 for the genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A-1).
Mencke P; Hanss Z; Jarazo J; Massart F; Rybicki A; Petkovski E; Glaab E; Boussaad I; Bonifati V; Christian Schwamborn J; Mandemakers W; Krüger R
Stem Cell Res; 2022 Jul; 62():102815. PubMed ID: 35617842
[TBL] [Abstract][Full Text] [Related]
13. Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004).
Novak G; Finkbeiner S; Skibinski G; Bernini M; Donato C; Skupin A
Stem Cell Res; 2022 May; 61():102765. PubMed ID: 35378365
[TBL] [Abstract][Full Text] [Related]
14. Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.
Barbuti P; Antony P; Santos B; Massart F; Cruciani G; Dording C; Arias J; Schwamborn J; Krüger R
Cells; 2020 Sep; 9(9):. PubMed ID: 32927687
[TBL] [Abstract][Full Text] [Related]
15. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation.
Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH
Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822
[TBL] [Abstract][Full Text] [Related]
16. The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset.
Periñán MT; Gómez-Garre P; Blauwendraat C; Mir P; Bandres-Ciga S;
Neurobiol Aging; 2021 Jan; 97():144.e1-144.e3. PubMed ID: 32948353
[TBL] [Abstract][Full Text] [Related]
17. Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell-Derived A9 Dopaminergic Neurons.
Pu J; Lin L; Jiang H; Hu Z; Li H; Yan Z; Zhang B; Feng J
Mov Disord; 2023 Jul; 38(7):1273-1281. PubMed ID: 37166002
[TBL] [Abstract][Full Text] [Related]
18. Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.
Singh Dolt K; Hammachi F; Kunath T
Brain Pathol; 2017 Jul; 27(4):545-551. PubMed ID: 28585381
[TBL] [Abstract][Full Text] [Related]
19. Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.
Birsa N; Norkett R; Wauer T; Mevissen TE; Wu HC; Foltynie T; Bhatia K; Hirst WD; Komander D; Plun-Favreau H; Kittler JT
J Biol Chem; 2014 May; 289(21):14569-82. PubMed ID: 24671417
[TBL] [Abstract][Full Text] [Related]
20. Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q
Romero-Moya D; Santos-Ocaña C; Castaño J; Garrabou G; Rodríguez-Gómez JA; Ruiz-Bonilla V; Bueno C; González-Rodríguez P; Giorgetti A; Perdiguero E; Prieto C; Moren-Nuñez C; Fernández-Ayala DJ; Victoria Cascajo M; Velasco I; Canals JM; Montero R; Yubero D; Jou C; López-Barneo J; Cardellach F; Muñoz-Cánoves P; Artuch R; Navas P; Menendez P
Stem Cells; 2017 Jul; 35(7):1687-1703. PubMed ID: 28472853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
